- For detail on any of these news items click here
- For information regarding Merkel cell carcinoma research and patient care click here.
- Dr. Nghiem receives the American Cancer Society Legacy & Leadership Award: Find Cures Award. Legacy & Leadership Celebration, September 13, 2012
- March 29, 2012, Dr. Nghiem was honored at an event celebrating his selection as the first Michael Piepkorn Endowed Chair in Dermatology Research chair holder.
- Dr. Nghiem was invited to participate at the Society of Dermatology Physician Assistants Summer Dermatology Conference, July 2012 in Seattle, WA. Listen to the podcast “Merkel cell carcinoma: Toward optimal management of an often-lethal skin malignancy.”
- Jay Bradner, collaborator and former trainee, is featured in Nature story on new approaches to treating cancer (link to pdf attached).
- Dr. Paul Nghiem was appointed Professor, Division of Dermatology, Department of Medicine; Adjunct Professor, Department of Pathology & Department of Oral Health Sciences, July 2012.
- Dr. Nghiem was appointed to the Michael Piepkorn Endowed Chair in Dermatology Research. October, 2011.
- The Nghiem lab is awarded an R01 grant from the NCI to study humoral and cellular immunity in polyomavirus-linked Merkel cell carcinoma. August, 2011.
- Paul Nghiem discusses Americans' higher incidence of skin cancer on the left side because of where we drive in our cars on KIRO with Chris Sullivan: link. June, 2011.
- Paul Nghiem discusses sun exposure, skin cancer, and other skin-related issues on KUOW's "The Conversation" with Ross Reynolds: link. June, 2011.
- Dr. Paulson's study of risk of melanoma and Merkel cell carcinoma shows that about one in ten of these cancers is likely associated with exposure while driving because these cancers occur more often on the left arm than the right arm. In Australia, where drivers sit on the opposite side of the car, the risk is reversed from sun-associated skin cancers: paper. June, 2011.
- Dr. Bianca Lemos is the lead author on a paper that describes: 1) the outcomes of 5,823 Merkel cell carcinoma patients in the National Cancer Data Base and 2) the derivation of a new concensus staging system, now in use world-wide. Aug 2010.
- Dr. Christine Fang is the lead author on a paper, published in Cancer, that described the effective use of radiation therapy alone (without surgery) to control Merkel cell carcinoma that has spread to the lymph nodes. April 2010.
- Renee Thibodeau, former Nghiem lab Research Scientist (2008-2010) begins medical school in Boston with a splash: TV coverage of her "Maine Program." Aug 2009.
- Former Research Fellow, James Bradner, M.D.
establishes his own independent research lab at Dana-Farber Cancer Institute. See: The Bradner Lab webpage for more inforamtion. Oct 2009
- Dr. Nghiem speaks at Yale University's Dermatology Seminar Series, "Caffeine and Skin Cancer: What's the Buzz?" Oct 2009
- UW Medicine/Seattle Public Library Lecture Series hosted Dr. Nghiem's presentation: "Does caffeine reduce the risk of skin cancer?" Click here for a pdf of the presentation slides. Click here to listen to the audio recording of the presentation that accompanies the slides. Oct 2009
- Olga Afanasiev, MD/PhD student joins the lab. Aug 2009
- Andy Tegeder, Medical Student joins the lab. Aug 2009
- Dr. Nghiem is featured in a Seattle Magazine article. June 2009
- Dr. Nghiem is featured in a City Living Seattle article. May 2009
- Dr. Shinichi Koba from Saga Medical School in Japan joins the lab. April 2009
- Masoki Kawasumi and Tim Heffernan publish a possible rationale for caffeine's UV protective effects. The article is met with great press coverage. Feb 2009
- Dr. Nghiem is featured on Seattle King 5's Cancer Breakthroughs special. Dec 2008
- Miranda Schmidt, UW undergraduate joins the lab. Dec 2008
- Sherry Lee, UW undergraduate joins the lab. Sept 2008
- Heather Sloan, RN/BS, from UW and Renee Thibodeau, BS, from Whitman College join the lab. June 2008
- Dr. Nghiem discusses the role of caffeine in skin cancer prevention to Science Central. April 2008.
We gratefully acknowledge our funding sources: